Jeremy Sokolove

Jeremy Sokolove is a seasoned medical professional with extensive experience in clinical development and pharmacology. Currently serving as Chief Medical Officer at Vor Bio since November 2025, Jeremy has previously held key leadership roles at Roivant Sciences, Odyssey Therapeutics, and GSK. At Roivant Sciences, Jeremy supported therapeutic evaluation and operational leadership while at Odyssey Therapeutics, directed clinical development strategies for a diverse drug portfolio. As Senior Vice President at GSK, Jeremy contributed to early phase clinical development and strategic initiatives across the organization. Prior positions include Vice President at AbbVie, where Jeremy led immunology translational science, and Clinical Assistant Professor at Stanford University School of Medicine, overseeing a translational immunology laboratory. Jeremy's educational background includes an M.D. from Boston University School of Medicine and training at both Boston University Medical Center and Stanford University School of Medicine.